expert perspectives

in Prostate Cancer

Expert Perspectives in Prostate Cancer to Cover Key Topics in Prostate Cancer Treatment

Overview

Expert Perspectives delivers health care providers with insights from key thought leaders on the latest advancements and current practices in medicine, in a concise and timely format. This issue of Expert Perspectives in Prostate Cancer will feature selected topics in Prostate Cancer that we hope you will find of value in your clinical practice.

The clinicians who were surveyed selected the following experts and topics.

Community-Selected Experts: 

Peter R. Carroll, MD, MPH

Ken and Donna Derr – Chevron Distinguished Professor
Taube Family Distinguished Professor in Urology
Department of Urology
UCSF - Helen Diller Comprehensive Cancer Center
University of California, San Francisco
San Francisco, CA

Daniel J. George, MD

Professor of Medicine and Surgery
Divisions of Medical Oncology and Urology
Director, Genitourinary Oncology
Duke Cancer Institute
Duke University Medical Center
Durham, NC

Oliver Sartor, MD

C. E. and Bernadine Laborde Professor of Cancer Research
Medical Director, Tulane Cancer Center
Associate Dean for Oncology
Tulane University School of Medicine
New Orleans, LA


Community-Selected Topics: 

Expert Roundtables

    Beyond Conventional Therapy for Managing Advanced Prostate Cancer
    Use of Prognostic Biomarkers for Avoiding the Overtreatment of Localized Prostate Cancer
    Treatment Sequencing in Patients With Castration-Resistant Prostate Cancer
    Targeted Therapy for Metastatic Castration-Resistant Prostate Cancer: Organized Approach to Genomic Evaluation

Clinical Topic Updates

    Prostate-Specific Membrane Antigen–Targeted Radioligand Therapy for Advanced Prostate Cancer
    Imaging Techniques in Metastatic Prostate Cancer
    Standards of Medical Care for Patients With Advanced Prostate Cancer
    Development and Prevalence of Castration-Resistant Prostate Cancer Subtypes

Patient Care Perspectives 

    Analyzing Diagnostic Tools in Advanced Prostate Cancer
    Optimization of Whole-Patient Care in Advanced Prostate Cancer
    Radioligand Therapy for Metastatic Castration-Resistant Prostate Cancer
    Individualizing Management in Advanced Prostate Cancer: Patient-Centered Metrics

More in Prostate Cancer

Thumb

Prostate Cancer

Identifying the High-Risk Patient: Prognostic Markers in Advanced Prostate Cancer

Expert Roundtables by Glen Gejerman, MD, Daniel J. George, MD, William K. Oh, MD, and Neal D. Shore, MD, FACS

Although the incidence of metastatic prostate cancer decreased with the introduction of PSA-based screening, prostate cancer will still be responsi...READ MORE

Thumb

Prostate Cancer

Newer PET/CT Imaging Techniques Promise to Improve Detection of Metastatic Prostate Cancer

Patient Care Perspectives by Peter R. Carroll, MD, MPH, Neal D. Shore, MD, FACS

The question of defining metastatic disease with available imaging techniques is an important one. Globally, current standard imaging techniques in...READ MORE

Thumb

Prostate Cancer

Newer Options for Osseous Metastases in Advanced Prostate Cancer

Clinical Topic Updates by Daniel J. George, MD, Neal D. Shore, MD, FACS

As with other epithelial cancers, metastasis to the bone is a sentinel event in the development of advanced prostate cancer. The bone microenvironm...READ MORE

More In Oncology

Non-Small Cell Lung Cancer

Biomarkers for Response to Immune Checkpoint Inhibition

Clinical Topic Updates
by Bruce E. Johnson, MD

Non-Small Cell Lung Cancer

Newer Targets and Therapies for Non–Small Cell Lung Cancer

Expert Roundtables
by Jeffrey Crawford, MD; Bruce E. Johnson, MD; and Gregory J. Riely, MD, PhD